vs
芝商所（CME）与百济神州（ONC）财务数据对比。点击上方公司名可切换其他公司
芝商所的季度营收约是百济神州的1.3倍（$1.9B vs $1.5B），百济神州净利率更高（4.4% vs 0.1%，领先4.4%），百济神州同比增速更快（32.8% vs 14.5%），过去两年百济神州的营收复合增速更高（41.2% vs 10.8%）
芝商所是总部位于美国伊利诺伊州芝加哥的金融服务企业，为全球规模最大的金融衍生品交易所运营商，旗下拥有芝加哥商品交易所、芝加哥期货交易所、纽约商业交易所、纽约商品交易所等交易平台，覆盖农产品、货币、能源等品类交易，同时持有标普道琼斯指数27%的股权。
BeOne Medicines（原百济神州）是一家跨国肿瘤领域制药企业，专注于癌症治疗创新药物的研发与商业化，致力于为全球癌症患者提供更有效、可及性更高的治疗方案，改善患者的生存质量与预后。
CME vs ONC — 直观对比
营收规模更大
CME
是对方的1.3倍
$1.5B
营收增速更快
ONC
高出18.4%
14.5%
净利率更高
ONC
高出4.4%
0.1%
两年增速更快
ONC
近两年复合增速
10.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.9B | $1.5B |
| 净利润 | $1.2M | $66.5M |
| 毛利率 | — | 90.5% |
| 营业利润率 | 0.1% | 12.4% |
| 净利率 | 0.1% | 4.4% |
| 营收同比 | 14.5% | 32.8% |
| 净利润同比 | 20.7% | 143.8% |
| 每股收益（稀释后） | — | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CMEONC
| Q1 26 | $1.9B | — | ||
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.5B | $1.4B | ||
| Q2 25 | $1.7B | $1.3B | ||
| Q1 25 | $1.6B | $1.1B | ||
| Q4 24 | $1.5B | $1.1B | ||
| Q3 24 | $1.6B | $1.0B | ||
| Q2 24 | $1.5B | $929.2M |
净利润CMEONC
| Q1 26 | $1.2M | — | ||
| Q4 25 | $1.2B | $66.5M | ||
| Q3 25 | $908.0M | $124.8M | ||
| Q2 25 | $1.0B | $94.3M | ||
| Q1 25 | $956.2M | $1.3M | ||
| Q4 24 | $874.6M | $-151.9M | ||
| Q3 24 | $912.8M | $-121.3M | ||
| Q2 24 | $883.2M | $-120.4M |
毛利率CMEONC
| Q1 26 | — | — | ||
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 86.1% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 85.1% |
营业利润率CMEONC
| Q1 26 | 0.1% | — | ||
| Q4 25 | 61.8% | 12.4% | ||
| Q3 25 | 63.3% | 11.5% | ||
| Q2 25 | 66.7% | 6.7% | ||
| Q1 25 | 67.5% | 1.0% | ||
| Q4 24 | 62.1% | -7.0% | ||
| Q3 24 | 64.6% | -12.0% | ||
| Q2 24 | 65.3% | -11.5% |
净利率CMEONC
| Q1 26 | 0.1% | — | ||
| Q4 25 | 71.7% | 4.4% | ||
| Q3 25 | 59.1% | 8.8% | ||
| Q2 25 | 60.6% | 7.2% | ||
| Q1 25 | 58.2% | 0.1% | ||
| Q4 24 | 57.3% | -13.5% | ||
| Q3 24 | 57.6% | -12.1% | ||
| Q2 24 | 57.6% | -13.0% |
每股收益（稀释后）CMEONC
| Q1 26 | — | — | ||
| Q4 25 | $3.24 | $0.05 | ||
| Q3 25 | $2.49 | $0.08 | ||
| Q2 25 | $2.81 | $0.06 | ||
| Q1 25 | $2.62 | $0.00 | ||
| Q4 24 | $2.40 | $-0.10 | ||
| Q3 24 | $2.50 | $-0.09 | ||
| Q2 24 | $2.42 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.4B | $4.5B |
| 总债务越低越好 | $3.4B | $836.4M |
| 股东权益账面价值 | — | $4.4B |
| 总资产 | $202.0B | $8.2B |
| 负债/权益比越低杠杆越低 | — | 0.19× |
8季度趋势，按日历期对齐
现金及短期投资CMEONC
| Q1 26 | $2.4B | — | ||
| Q4 25 | $4.5B | $4.5B | ||
| Q3 25 | $2.6B | $4.0B | ||
| Q2 25 | $2.1B | $2.8B | ||
| Q1 25 | $1.5B | $2.5B | ||
| Q4 24 | $3.0B | $2.6B | ||
| Q3 24 | $2.4B | $2.7B | ||
| Q2 24 | $1.9B | $2.6B |
总债务CMEONC
| Q1 26 | $3.4B | — | ||
| Q4 25 | — | $836.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益CMEONC
| Q1 26 | — | — | ||
| Q4 25 | $28.7B | $4.4B | ||
| Q3 25 | $28.2B | $4.1B | ||
| Q2 25 | $27.7B | $3.8B | ||
| Q1 25 | $27.0B | $3.5B | ||
| Q4 24 | $26.5B | $3.3B | ||
| Q3 24 | $28.2B | $3.4B | ||
| Q2 24 | $27.6B | $3.4B |
总资产CMEONC
| Q1 26 | $202.0B | — | ||
| Q4 25 | $198.4B | $8.2B | ||
| Q3 25 | $187.1B | $7.6B | ||
| Q2 25 | $179.9B | $6.3B | ||
| Q1 25 | $157.8B | $5.8B | ||
| Q4 24 | $137.4B | $5.9B | ||
| Q3 24 | $137.8B | $5.8B | ||
| Q2 24 | $123.4B | $5.7B |
负债/权益比CMEONC
| Q1 26 | — | — | ||
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $417.3M |
| 自由现金流经营现金流 - 资本支出 | — | $379.8M |
| 自由现金流率自由现金流/营收 | — | 25.4% |
| 资本支出强度资本支出/营收 | — | 2.5% |
| 现金转化率经营现金流/净利润 | — | 6.28× |
| 过去12个月自由现金流最近4个季度 | — | $941.7M |
8季度趋势，按日历期对齐
经营现金流CMEONC
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $417.3M | ||
| Q3 25 | $968.1M | $402.6M | ||
| Q2 25 | $1.1B | $263.6M | ||
| Q1 25 | $1.1B | $44.1M | ||
| Q4 24 | $1.0B | $75.2M | ||
| Q3 24 | $1.0B | $188.4M | ||
| Q2 24 | $776.9M | $-95.6M |
自由现金流CMEONC
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $379.8M | ||
| Q3 25 | $949.7M | $354.5M | ||
| Q2 25 | $1.0B | $219.8M | ||
| Q1 25 | $1.1B | $-12.3M | ||
| Q4 24 | $991.7M | $-17.3M | ||
| Q3 24 | $973.2M | $54.7M | ||
| Q2 24 | $758.7M | $-205.5M |
自由现金流率CMEONC
| Q1 26 | — | — | ||
| Q4 25 | 66.8% | 25.4% | ||
| Q3 25 | 61.8% | 25.1% | ||
| Q2 25 | 61.5% | 16.7% | ||
| Q1 25 | 67.1% | -1.1% | ||
| Q4 24 | 65.0% | -1.5% | ||
| Q3 24 | 61.4% | 5.5% | ||
| Q2 24 | 49.5% | -22.1% |
资本支出强度CMEONC
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | 2.5% | ||
| Q3 25 | 1.2% | 3.4% | ||
| Q2 25 | 1.1% | 3.3% | ||
| Q1 25 | 0.9% | 5.0% | ||
| Q4 24 | 1.7% | 8.2% | ||
| Q3 24 | 1.9% | 13.3% | ||
| Q2 24 | 1.2% | 11.8% |
现金转化率CMEONC
| Q1 26 | — | — | ||
| Q4 25 | 0.96× | 6.28× | ||
| Q3 25 | 1.07× | 3.22× | ||
| Q2 25 | 1.03× | 2.79× | ||
| Q1 25 | 1.17× | 34.71× | ||
| Q4 24 | 1.16× | — | ||
| Q3 24 | 1.10× | — | ||
| Q2 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
